merged_alzheimers-blood-test.txt
<question_number>1</question_number>
<answer>There are currently no effective therapies to offer individuals diagnosed with Alzheimer's disease before cognitive impairment manifests.</answer>
<question_number>2</question_number>
<answer>The blood test was wrong about 10% of the time, while primary care doctors were wrong 41% of the time.</answer>
<question_number>3</question_number>
<answer>Many individuals with subjective cognitive decline do not ultimately develop Alzheimer's disease.</answer>
<question_number>4</question_number>
<answer>Seamless integration of blood test analysis into hospital laboratory systems, rather than relying on external labs.</answer>
<question_number>5</question_number>
<answer>ptau-217, a specific form of the tau protein.</answer>
<question_number>6</question_number>
<answer>Exclusively within the context of research studies.</answer>
<question_number>7</question_number>
<answer>Kidney disease.</answer>
<question_number>8</question_number>
<answer>The potential for anxiety and negative psychological reactions to a positive test result in the absence of preventative treatments.</answer>
<question_number>9</question_number>
<answer>41%</answer>
<question_number>10</question_number>
<answer>Increased access to early screening for cognitive impairment, potentially leading to earlier diagnosis and intervention.</answer>